Public Reporting


ACO Name and Location

MD Valuecare, LLC
8001 Franklin Farms Drive, Suite 130
Richmond, VA 23229

ACO Primary Contact

Shannon Lodge, ACO Administrator
8001 Franklin Farms Drive, Suite 130
Richmond VA 23229
[email protected]

Organizational Information

ACO Participants

ACO ParticipantsACO Participant in Joint Venture
Commonwealth Primary CareN
Dominion Medical AssociatesN
Virginia Diabetes and EndocrinologyN

ACO Governing Body

Member First NameMember Last NameMember Title/PositionMember's Voting PowerMembership TypeACO Participant Legal Business Name, if applicable
CathyCawleyManager11.1%ACO ParticipantCommonwealth Primary Care
DamianCovington, MDManager11.1%ACO ParticipantDominion Medical Associates
LarryGooss, MDManager11.1%ACO ParticipantCommonwealth Primary Care
AnnHoneycuttBoard Vice Chair, Manager11.1%Other Representative
SheaPuttkammer, MDManager11.1%ACO ParticipantVirginia Diabetes and Endocrinology
BertWilsonManager11.1%Medicare Beneficiary Representative
DavidTaminger, MDManager11.1%ACO ParticipantCommonwealth Primary Care
StephenYoung, MDBoard Chair, Manager11.1%ACO ParticipantVirginia Diabetes and Endocrinology
J. KenZelenak, MDManager11.1%ACO ParticipantCommonwealth Primary Care

Key Clinical and Administrative Leadership

  • ACO Executive: Shannon Lodge, MHA
  • Medical Director: J. Ken Zelenak, MD
  • Compliance Officer: Shannon Lodge, MHA
  • Quality Assurance/Improvement Officer: J. Ken Zelenak, MD

ACO Committees and Committee Leadership

Committee NameCommittee Leader Name and Position
Quality CommitteeJ. Ken Zelenak, MD - Chair
Managing CommitteeRachel Downey - Chair
Specialist Mobilization CommitteeMark Monahan, MD – Co-Chair, Johnny Wong, MD – Co-Chair

Types of ACO Participants, or Combinations of Participants, that Formed the ACO

Network of individual practices of ACO professionals.

Shared Savings and Losses

Amount of Shared Savings and Losses

Third Agreement Period

  • Performance Year 2022, $4,654,763
  • Performance Year 2021, $4,619,483
  • Performance Year 2020, $1,894,328

Second Agreement Period

  • Performance Year 2019, $0
  • Performance Year 2018, $0
  • Performance Year 2017, $3,701,488

First Agreement Period

  • Performance Year 2016, $1,809,663
  • Performance Year 2015, $0
  • Performance Year 2014, $0

How Shared Savings Are Distributed

Third Agreement Period

Performance Year 2022

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 75%

Performance Year 2021

  • Proportion invested in infrastructure: 11%
  • Proportion invested in redesigned care processes/resources: 15%
  • Proportion of distribution to ACO participants: 74%

Performance Year 2020

  • Proportion invested in infrastructure: 25%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 65%

Second Agreement Period

Performance Year 2019 – N/A
Performance Year 2018 – N/A
Performance Year 2017

  • Proportion invested in infrastructure: 41%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 49%

First Agreement Period

Performance Year 2016

  • Proportion invested in infrastructure: 100%
  • Invested in redesigned care processes/resources: 0%
  • Proportion of distribution to ACO participants: 0%

Performance Year 2015 – N/A
Performance Year 2014 – N/A

Quality Performance Results

2022 Quality performance results are based on CMS Web Interface Measure Set

Measure #Measure NameCollection TypePerformance RateACO Mean
Quality ID# 001Diabetes: Hemoglobin A1c (HbA1c) Poor ControlCMS Web Interface5.8010.71
Quality ID# 134Preventative Care and Screening: Screening for Depression and Follow-up PlanCMS Web Interface92.5776.97
Quality ID# 236Controlling High Blood PressureCMS Web Interface81.8876.16
Quality ID# 318Screening for Future Fall RiskCMS Web Interface97.5687.83
Quality ID# 110Preventative Care and Screening: Influenza ImmunizationCMS Web Interface92.8077.34
Quality ID# 226Preventative Care and Screening: Tobacco Use: Screening and Cessation InterventionCMS Web Interface75.0079.27
Quality ID# 113Colorectal Cancer ScreeningCMS Web Interface84.3475.32
Quality ID# 112Breast Cancer ScreeningCMS Web Interface81.6878.07
Quality ID# 438Statin Therapy for the Prevention and Treatment of Cardiovascular DiseaseCMS Web Interface90.3786.37
Quality ID# 370Depression Remission at Twelve MonthsCMS Web Interface18.3316.03
CAHPS-1Getting Timely Care, Appointments, and InformationCAHPS84.9683.96
CAHPS-2How Well Providers CommunicateCAHPS93.7593.47
CAHPS-3Patient’s Rating of ProviderCAHPS92.7992.06
CAHPS-4Access to SpecialistsCAHPS73.0277.00
CAHPS-5Health Promotion and EducationCAHPS63.4662.68
CAHPS-6Shared Decision MakingCAHPS59.2360.97
CAHPS-7Health Status and Functional StatusCAHPS74.9373.06
CAHPS-8Care CoordinationCAHPS86.8885.46
CAHPS-9Courteous and Helpful Office StaffCAHPS91.4491.97
CAHPS-11Stewardship of Patient ResourcesCAHPS34.9425.62
Measure# 479Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS GroupsAdministrative Claims0.15240.1510
Measure# 484Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic ConditionsAdministrative Claims32.8330.97

For Previous Years’ Financial and Quality Performance Results, please visit

Fraud and Abuse Waivers

ACO Participation Waiver:

ACO Participation Waiver: The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

Parties to the arrangement: MD Valuecare, LLC and Laboratory Corporation of America Holdings
Date of arrangement: June 1, 2021
Items, services, goods, or facility provided: Grants to incorporate data analytics platforms to facilitate care coordination and promote outcomes of care. Incorporate Lab Corp’s lab data into clinical data to provide a more robust view of the ACO’s patient population.
Date and nature of any amendments to the arrangement, if applicable: December 1, 2022, Renewal Agreement